Non-diabetic control subjects n = 118 | Type 1 diabetes patients n = 401 | |
---|---|---|
Sex (male/female) | 44.2%/54.8% | 49.5%/50.5% |
Age (years)* | 36 (29-44.5) | 34.7 (27.8-43) |
- 675 T → A CYBA genotypes | ||
T/T | 101 (85.6%) | 351 (87.5%) |
T/A | 17 (14.4%) | 47 (11.7%) |
A/A | 0 (0%) | 3 (0.8%) |
- 129 C → T GCLC genotypes | ||
C/C | 97 (82.2%) | 333 (83%) |
C/T | 21 (17.8%) | 64 (16%) |
T/T | 0 (0%) | 4 (1%) |
- 65 T → C GPX3 genotypes | ||
T/T | 87 (73.7%) | 298 (74.3%) |
T/C | 28 (23.8%) | 98 (24.5%) |
C/C | 3(2.5%) | 5 (1.2%) |